Analyte Health

Analyte Health is a U.S.-based digital health company that provides direct-to-consumer diagnostics, telehealth consultations, and prescription fulfillment across consumer healthcare categories. The company operates a technology-enabled platform that integrates lab ordering, physician access, treatment workflows, and patient support, with a strong emphasis on convenience, privacy, and affordability. Its portfolio includes online brands spanning lab testing, sexual health, paternity testing, telemedicine, and treatment services. Following its acquisition by Brightstar Capital Partners in August 2025, Analyte Health continues to operate actively under founder and CEO Fiyyaz Pirani. The business is commercial-stage and focused on scalable healthcare service delivery rather than traditional drug R&D.